Replies to post #2566 on Galectin Therapeutics Inc. (GALT)

[gss2003]

It matters for how much dilution is necessary to complete the CX trial. The less the better.

Certainly even if there are 50M shares by December 2017 and the results are good it can still be well above $10/shr.